Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- DM3512P - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#DM3512P, RRID:AB_1008499
- Product name
- anti VEGFR-3 / Flt-4
- Antibody type
- Monoclonal
- Antigen
- Purified recombinant Human Vascular Endothelial Growth Factor Receptor 3 (rh VEGFR-3/FLT-4) extracellular domain.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- (3C3) 9D9
- Vial size
- 0.1 mg
Submitted references Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma.
Davids MS, Charlton A, Ng SS, Chong ML, Laubscher K, Dar M, Hodge J, Soong R, Goh BC
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Sep 10;27(26):e97-100
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Sep 10;27(26):e97-100
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western analysis of recombinant Human soluble VEGFR-3/FLT-4.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Immunofluorescence staining of human VEGFR-3/FLT-4 (red) in hFlt4-transfected MG63 cells. Monoclonal mouse anti-human FLT-4 clone 9D9 (Cat.-No DM3512P) and polyclonal rabbit anti-human FLT-4 (D) Cat.-No DP3511: A and C are negative control with secondary antibody only; B (mAb) and D (pAb) with specific antibodies against human FLT-4.The experiment was performed by the research group of Dr. Wolfgang Holnthoner, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration, Donaueschingenstrasse 13, A-1200 Vienna, Austria.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- FACS analysis with HDMVEC and HUVEC.
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- FACS analysis with primary human dermal lymphatic endothelial cells (HDLEC).